Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus

[1]  Z. Vanaki,et al.  Self-perception in Iranian adolescents with diabetes: a qualitative study , 2015, Journal of Diabetes & Metabolic Disorders.

[2]  D. Ye,et al.  Association study of glucocorticoid receptor genetic polymorphisms with efficacy of glucocorticoids in systemic lupus erythematosus: A prospective cohort study , 2013, Autoimmunity.

[3]  M. Jolly,et al.  Top 10 Recent Developments in Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus , 2013, Current Rheumatology Reports.

[4]  D. Ye,et al.  Impact of Environmental Factors on Efficacy of Glucocorticoids in Chinese Population with Systemic Lupus Erythematosus , 2013, Inflammation.

[5]  A. Lewiński,et al.  Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland , 2012, Molecular Biology Reports.

[6]  D. Ye,et al.  Seasonal distribution of systemic lupus erythematosus activity and its correlation with climate factors , 2012, Rheumatology International.

[7]  S. Bombardieri,et al.  Glucocorticoids in systemic lupus erythematosus. , 2011, Clinical and experimental rheumatology.

[8]  M. Jolly,et al.  The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort , 2011, Lupus.

[9]  D. D. de Quervain,et al.  Relationship of a common polymorphism of the glucocorticoid receptor gene to traumatic memories and posttraumatic stress disorder in patients after intensive care therapy , 2011, Critical care medicine.

[10]  C. Pariante,et al.  The glucocorticoid receptor: Pivot of depression and of antidepressant treatment? , 2011, Psychoneuroendocrinology.

[11]  M. Johannesson,et al.  Regional differences in health status in China: population health-related quality of life results from the National Health Services Survey 2008. , 2011, Health & place.

[12]  M. Petri.  Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody–Positive Patients , 2011, Current rheumatology reports.

[13]  G. Chrousos,et al.  The human glucocorticoid receptor: Molecular basis of biologic function , 2010, Steroids.

[14]  S. Lamberts,et al.  Clinical Features Associated with Glucocorticoid Receptor Polymorphisms , 2009, Annals of the New York Academy of Sciences.

[15]  J. Piette,et al.  Hydroxychloroquine in systemic lupus erythematosus , 2007, The Lancet.

[16]  V. Strand,et al.  Health-related quality of life in patients with systemic lupus erythematosus: an update. , 2007, Annals of the Academy of Medicine, Singapore.

[17]  A. Page,et al.  Evaluating the clinical significance of responses by psychiatric inpatients to the mental health subscales of the SF-36. , 2007, Journal of affective disorders.

[18]  G. Hughes,et al.  Systemic lupus erythematosus , 2001, The Lancet.

[19]  D. D'cruz.  Systemic lupus erythematosus , 2006, BMJ : British Medical Journal.

[20]  Whoqol Group,et al.  Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL) , 2004, Quality of Life Research.

[21]  S. Tett,et al.  Population Pharmacokinetics of Hydroxychloroquine in Patients With Rheumatoid Arthritis , 2003, Therapeutic drug monitoring.

[22]  D. Franchimont,et al.  Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[24]  Y. Nasuhara,et al.  Ligand‐induced differentiation of glucocorticoid receptor (GR) trans‐repression and transactivation: preferential targetting of NF‐κB and lack of I‐κB involvement , 1999, Biochemical Society transactions.

[25]  C. Malchoff,et al.  Glucocorticoid Resistance , 2020, Definitions.

[26]  G. Chrousos,et al.  5 Glucocorticoid resistance , 1994 .

[27]  S. Detera-Wadleigh,et al.  The genomic structure of the human glucocorticoid receptor. , 1991, The Journal of biological chemistry.

[28]  U. Francke,et al.  The glucocorticoid receptor gene is in 5q–q32 , 1989 .

[29]  U. Francke,et al.  The glucocorticoid receptor gene is in 5q31-q32 [corrected]. , 1989, Genomics.